Health Technology Startup Fitterfly Secures $12 Million In Its Series A Round

4
medtech

Health technology startup In a $12 million Series A round led by Amazon Smbhav Venture Fund and Fireside Ventures, Fitterfly raised funding. This is Amazon Smbhav’s first investment in Indian health technology.

This round also included participation from Venture Catalysts, 9 Unicorns, Nihar Parikh of 4point0 Health Ventures, and Sriram Natarajan of Molbio.

In 2021, the Amazon Smbhav Venture Fund had promised to invest $250 million in start-ups in the fields of agriculture, healthcare, and SMB (small and medium companies).

The additional money will be utilized to broaden the reach of Fitterfly’s digital treatments and clinically-proven programs to prevent, manage, and reverse diabetes as well as Diabefly’s reach.

In the fight against chronic illnesses, Kanwaljit Singh, the founder and managing partner of Fireside Ventures, which co-led the fundraising, stated that the combination of technology and patient-centered care is urgently needed and would lead to improved outcomes. I’ve known Arbinder for more than ten years, and his background as a physician and serial entrepreneur is tremendously valuable for creating a successful international business. We were confident in Fitterfly’s talents in this area when we funded them last year. We expect to see the same passion in them as they broaden their reach as we renew our support for them now.

With a 360-degree approach to treatment and professionally recommended therapy from more than 200 doctors throughout India, Fitterfly has over 20,000 patients.

Fitterfly, with its headquarters in Navi Mumbai and more than 200 people, was established by Dr. Arbinder Singal and Shailesh Gupta in 2016. The firm has so far raised $16.6 million in total.